| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/17/2001 | EP1068236A1 Human oxidized ldl receptor |
| 01/17/2001 | EP1068221A2 Template associated npy y2-receptor agonists |
| 01/17/2001 | EP1068212A1 THIAZOLO 4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS |
| 01/17/2001 | EP1068207A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES |
| 01/17/2001 | EP1068206A1 Aminoalkyl substituted pyrrolo 2,3-b]pyridine and pyrrolo 2,3-d]pyrimidine derivatives: modulators of crf1 receptors |
| 01/17/2001 | EP1068205A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino 2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino 4,5-b]indole derivatives: crf1 specific ligands |
| 01/17/2001 | EP1068194A1 Pde iv inhibiting pyridine derivatives |
| 01/17/2001 | EP1068189A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors |
| 01/17/2001 | EP1068187A1 Pyrazole inhibitors of cytokine production |
| 01/17/2001 | EP1068180A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
| 01/17/2001 | EP1067963A1 Hiv-specific cytotoxic t-cell responses |
| 01/17/2001 | EP1067962A2 Derivatives of pneumococcal choline binding proteins for vaccines |
| 01/17/2001 | EP1067956A2 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| 01/17/2001 | EP1067954A1 USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE |
| 01/17/2001 | EP1067948A1 Use of extracts of bearberry leaves (arctostaphylos uva ursi), birch leaves (betula), horsetail (equisetum) and stinging nettle (urtica) |
| 01/17/2001 | EP1067947A1 Use of extracts of echinacea pallida and echinacea angustifolia, dandelion (taraxacum) and plantain (plantago) |
| 01/17/2001 | EP1067940A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 01/17/2001 | EP1067930A1 Antagonists of gonadotropin releasing hormone |
| 01/17/2001 | EP1067926A2 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins |
| 01/17/2001 | EP1067904A1 Solid, quick dissolving cetirizine formulations |
| 01/17/2001 | EP1067893A2 Human galactosyl transferases |
| 01/17/2001 | EP0730590B1 isoxazoline and isoxazole fibrinogen receptor antagonists |
| 01/17/2001 | EP0680315B1 Method for preparing a viral aerosol |
| 01/17/2001 | EP0581959B1 Use of macrolide compounds for eye diseases |
| 01/17/2001 | CN1280579A Novel polymorphic forms of cipamfylline |
| 01/17/2001 | CN1280568A Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 01/17/2001 | CN1280560A Adamantane derivatives |
| 01/17/2001 | CN1280504A Vaccines with an LTB adjuvant |
| 01/17/2001 | CN1280502A Cyclosporin-containing microemulsion preconcentrate composition |
| 01/17/2001 | CN1280008A Strong anti-oxidative composite capsule of grape seed extract OPC and its producing method |
| 01/17/2001 | CN1279978A Ginkgo and gastrodia taber capsule |
| 01/17/2001 | CN1279963A Guilingbao powder-a kind of health food |
| 01/17/2001 | CN1060770C Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
| 01/17/2001 | CN1060768C Pyrazoles and pyrazolopyrimidines |
| 01/17/2001 | CN1060677C Preparation for senile disease |
| 01/17/2001 | CN1060667C Fumigant for reinforcing body primordial energy |
| 01/16/2001 | US6175021 Human non-pancreatic secretory phospholipase a2 (spla2); inhibits release of arachidonic acid to treat septic shock; ((3-(2-amino-1,2-dioxoethyl)-2-methyl-1-(phenylmethyl)-1h-indol-4 -yl)oxylacetic acid, for example |
| 01/16/2001 | US6175013 1-(2-methoxybenzyl)-2-((4-phenyl-1-piperazinyl)methyl)-4-(1h -indol-3-ylmethyl)-2-imidazoline, for example; adminstering to treat anxiety, depression, psychosis, and schizophrenia |
| 01/16/2001 | US6174994 7TM receptor (H2CAA71) |
| 01/16/2001 | US6174993 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 01/16/2001 | US6174910 Treating pathological symptoms of vascular proliferation disorders which can be reduced or inhibited by apoptosis, by administering at.sub.1(angiotensin) receptor antagonist compound such as valsartan, irbesartan, losatran etc. |
| 01/16/2001 | US6174895 1-aryl-3-arylmethyl-1,8-naphthyridin-4(1H)-ones |
| 01/16/2001 | US6174887 Amide compounds and use of the same |
| 01/16/2001 | US6174873 Oral administration of adenosine analogs |
| 01/16/2001 | US6174872 Immunotherapy of allergic asthma in both its early and late stages by administering to the mucosa a polynucleotide encoding an asthma-initiating antigen and immunostimulatory neucleotide seqence stimulating the th1 lymhocytes |
| 01/16/2001 | US6174692 Detecting preferential antigen in sample; incubating monoclonal antibody with sample containing preferential antigen and detecting biinding |
| 01/16/2001 | US6174676 Cytokine-stress- and oncoprotein-activated human protein kinase kinases |
| 01/16/2001 | US6174530 Homogeneous polyoxime compositions and their preparation by parallel assembly |
| 01/16/2001 | US6174529 Oral therapy for the treatment of allergies and method of manufacture |
| 01/16/2001 | CA2314008A1 2-benzimidazolylamine compounds as orl1-receptor agonists |
| 01/16/2001 | CA2313899A1 Novel selective imune down regulation (sidr) mediated transplantation processes, processes for preventing or treating diseases in a subject, and compositions of matter comprising trained or programmed cells, tissues or organs useful for sidr establishment |
| 01/11/2001 | WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | WO2001002569A2 Human immune response molecules |
| 01/11/2001 | WO2001002551A2 Virus like particles, preparation and use in screening and functional genomics |
| 01/11/2001 | WO2001002550A2 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | WO2001002540A2 Adenoviral vectors for treating disease |
| 01/11/2001 | WO2001002437A1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 01/11/2001 | WO2001002406A1 Potassium channel blocking agents |
| 01/11/2001 | WO2001002388A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | WO2001002387A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors |
| 01/11/2001 | WO2001002381A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/11/2001 | WO2001002365A1 Ciprofloxacin hydrates and method for their production |
| 01/11/2001 | WO2001002349A1 Phenyl sulfamate derivatives |
| 01/11/2001 | WO2001002018A2 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 01/11/2001 | WO2001002011A1 REMEDIES FOR DISEASES CAUSED BY PTH OR PTHrP |
| 01/11/2001 | WO2001002007A1 Method for enhancing an immune response |
| 01/11/2001 | WO2001002005A2 Treatment of dentritic cells for induction of immune tolerance |
| 01/11/2001 | WO2001001988A1 Compounds having cytokine inhibitory activity |
| 01/11/2001 | WO2001001976A2 Composition comprising an extract of perna canaliculus, methylsulfonylmethane and glucosamine |
| 01/11/2001 | WO2001001748A2 Peptide compounds that bind her2 |
| 01/11/2001 | WO2000062801A3 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 01/11/2001 | WO2000062800A3 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 01/11/2001 | WO2000062657A3 Improvement of t cell mediated immunity |
| 01/11/2001 | WO2000061608A3 Low-molecular inhibitors of complement proteases |
| 01/11/2001 | WO2000059904A3 Compounds and methods to treat cardiac failure and other disorders |
| 01/11/2001 | WO2000059515A3 Immunomodulating polymers |
| 01/11/2001 | WO2000058466A3 Protease resistant flint analogs |
| 01/11/2001 | WO2000054803A3 Immunostimulatory nucleic acids and antigens |
| 01/11/2001 | WO2000053748A3 Casb618 polynucleotides and polypeptides and their use |
| 01/11/2001 | WO2000053596A3 Imidazole compounds as histamine h3 ligands |
| 01/11/2001 | WO2000051635A3 Emulsan and emulsan analogs immunization formulations and use |
| 01/11/2001 | WO2000046251A3 Human polyclonal antibodies from transgenic nonhuman animals |
| 01/11/2001 | DE19932315A1 Benzoylpyridazine Benzoylpyridazine |
| 01/11/2001 | DE19930177A1 Intermolekular assoziierende Verbindungen und diese umfassende Aggregate Inter-molecular compounds and associating this comprehensive aggregates |
| 01/11/2001 | CA2380875A1 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | CA2378477A1 Induction of immune tolerance |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/11/2001 | CA2376657A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | CA2376513A1 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | CA2373885A1 Therapeutic agent for diseases caused by pth or pthrp |
| 01/11/2001 | CA2373884A1 Method for enhancing an immune response |
| 01/11/2001 | CA2373882A1 Compounds having cytokine inhibitory activity |
| 01/11/2001 | CA2373352A1 Adenoviral vectors for treating disease |
| 01/10/2001 | EP1067141A1 A male-specific protein homologue involved in histocompatibility |
| 01/10/2001 | EP1066833A2 Cryopreserved cells, system for supplying cells on commission, and preventive or remedial method of infections or cancers |
| 01/10/2001 | EP1066396A1 Nucleic acid transfer vectors, compositions containing same and uses |
| 01/10/2001 | EP1066378A2 Lyst protein complexes and lyst interacting proteins |
| 01/10/2001 | EP1066319A1 Production methods and uses of a retrovirus |
| 01/10/2001 | EP1066316A1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 01/10/2001 | EP1066315A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease |